Description
LU177 DOTATATE
First action · last action
2021-01-13 · 2022-06-21
Transactions
2
First transaction's obligation
$935,179
Base + all options value (sum of deltas)
$376,285
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0169
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-01-13+$935,179= $935,179
- Mod P000012022-06-21-$558,894= $376,285
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-01-13 | +$935,179 | $935,179 | LU177 DOTATATE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-06-21 | −$558,894 | $376,285 | LU177 DOTATATE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JNM4NBNHFE66)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0132 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,200,000 | FY2026 |
| 36C26026N0121 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $996,874 | FY2026 |
| 36C24926N0263 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $823,062 | FY2026 |
| 36C25525N0282 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $166,146 | FY2025 |
| 36C25525N0176 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,362,395 | FY2025 |
| 36C25225F0044 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $631,354 | FY2025 |
Other recipients under Q527 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726C0004 | MOBILE IMAGING OF AMERICA CORP | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $892,500 | FY2026 |
| 36C25723P0301 | BRACCO DIAGNOSTICS INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $111,240 | FY2023 |
| 36C25723P0299 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $576,910 | FY2023 |
| 36C25723C0029 | TECH62 INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $299,800 | FY2023 |
| 36C25723N0024 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $552,543 | FY2023 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25721N0208_3600_36F79719D0169_3600 · retrieved 2026-09-26.